Marongiu A - Search Results

1

Impact of a selected Debaryomyces hansenii strain's inoculation on the quality of Sardinian fermented sausages.

Murgia MA, Marongiu A, Aponte M, Blaiotta G, Deiana P, Mangia NP. Murgia MA, et al. Among authors: marongiu a. Food Res Int. 2019 Jul;121:144-150. doi: 10.1016/j.foodres.2019.03.042. Epub 2019 Mar 19. Food Res Int. 2019. PMID: 31108735

2

Novel starters for old processes: use of Saccharomyces cerevisiae strains isolated from artisanal sourdough for craft beer production at a brewery scale.

Marongiu A, Zara G, Legras JL, Del Caro A, Mascia I, Fadda C, Budroni M. Marongiu A, et al. J Ind Microbiol Biotechnol. 2015 Jan;42(1):85-92. doi: 10.1007/s10295-014-1525-1. Epub 2014 Nov 12. J Ind Microbiol Biotechnol. 2015. PMID: 25387611

3

Radiomics Features from Positron Emission Tomography with [¹⁸F] Fluorodeoxyglucose Can Help Predict Cervical Nodal Status in Patients with Head and Neck Cancer.

Bianconi F, Salis R, Fravolini ML, Khan MU, Filippi L, Marongiu A, Nuvoli S, Spanu A, Palumbo B. Bianconi F, et al. Among authors: marongiu a. Cancers (Basel). 2024 Nov 7;16(22):3759. doi: 10.3390/cancers16223759. Cancers (Basel). 2024. PMID: 39594715 Free PMC article.

4

The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up.

Marongiu A, Nuvoli S, De Vito A, Mura A, Vargiu S, Spanu A, Madeddu G. Marongiu A, et al. J Clin Med. 2024 Sep 11;13(18):5373. doi: 10.3390/jcm13185373. J Clin Med. 2024. PMID: 39336859 Free PMC article.

5

Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy.

Putzu C, Serra R, Campus R, Fadda GM, Sini C, Marongiu A, Ginesu GC, Fois AG, Palmieri G, Zinellu A, Cossu A, Paliogiannis P. Putzu C, et al. Among authors: marongiu a. Curr Oncol. 2024 Aug 26;31(9):4955-4967. doi: 10.3390/curroncol31090367. Curr Oncol. 2024. PMID: 39329995 Free PMC article.

6

Combined bictegravir, emtricitabine and tenofovir alafenamide for treating people with HIV: a plain language summary of the BICSTaR study up to 1 year.

Esser S, Inciarte A, Levy I, D'Arminio Monforte A, Lambert JS, van Welzen B, Teruya K, Boffito M, Liu CE, Aydın OA, Thorpe D, Heinzkill M, Marongiu A, Cassidy T, Haubrich R, D'Amato L, Robineau O. Esser S, et al. Among authors: marongiu a. Future Microbiol. 2024;19(15):1273-1282. doi: 10.1080/17460913.2024.2391190. Epub 2024 Sep 4. Future Microbiol. 2024. PMID: 39229785 Free PMC article.

7

Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in treatment-naïve and treatment-experienced people with HIV: Findings from the Asia cohort of the BICSTaR study.

Tseng YT, Yang CJ, Kim YS, Choi JY, Wong CS, Lee KY, Lee JA, Chang J, Harrison R, Marongiu A, Lee SH, Hung CC. Tseng YT, et al. Among authors: marongiu a. J Microbiol Immunol Infect. 2024 Oct;57(5):760-770. doi: 10.1016/j.jmii.2024.07.003. Epub 2024 Jul 14. J Microbiol Immunol Infect. 2024. PMID: 39079772 Free article.

8

Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand?

Dondi F, Miceli A, Rovera G, Feudo V, Battisti C, Rondini M, Marongiu A, Mura A, Camedda R, De Feo MS, Conte M, Gorica J, Ferrari C, Nappi AG, Santo G. Dondi F, et al. Among authors: marongiu a. Bioengineering (Basel). 2024 Jul 14;11(7):714. doi: 10.3390/bioengineering11070714. Bioengineering (Basel). 2024. PMID: 39061796 Free PMC article. Review.

9

Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV from the Canadian cohort of the observational BICSTaR study.

Wong A, Brunetta J, De Wet J, Logue K, Loemba H, Saifi T, Mumm D, Marongiu A, Harrison R, Thorpe D, Trottier B. Wong A, et al. Among authors: marongiu a. Medicine (Baltimore). 2024 Apr 19;103(16):e37785. doi: 10.1097/MD.0000000000037785. Medicine (Baltimore). 2024. PMID: 38640301 Free PMC article.

10

Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up.

Marongiu A, Nuvoli S, De Vito A, Vargiu S, Spanu A, Madeddu G. Marongiu A, et al. Biomedicines. 2024 Feb 2;12(2):350. doi: 10.3390/biomedicines12020350. Biomedicines. 2024. PMID: 38397952 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters